EMA approves Dupixent as first biologic for COPD with elevated eosinophils
The European Medicines Agency (EMA) has granted approval to Dupixent (dupilumab) as a novel add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease ... Read More
Understanding asthma: Symptoms, complications, and management
Asthma is a chronic respiratory condition marked by several distressing symptoms that can significantly impact daily life. Characterized by episodes of breathing difficulty, wheezing, and ... Read More